Many patients depend on Amgen medicines for their treatment, and we are dedicated to ensuring that patients and physicians can continue to rely on the quality and availability of our medicines. Amgen strives to ensure our products are reliably supplied to every patient, every time.
High-quality and reliable manufacturing is every bit as important as scientific innovation. When making manufacturing choices, we base every decision on our guiding principle to deliver meticulous quality. Like all of our products, Amgen biosimilars will be held to the same high standards.
Beginning with the design of our medicines, Amgen builds in quality from the start and commits to making important investments to support that mission. Transforming complex therapeutic proteins from the laboratory into the large-scale production of safe and effective biologic medicines requires highly specialized knowledge and experience with processes, scientific standards, and quality systems. As a leader in biotech manufacturing, Amgen has invested over $1 billion into the company’s state-of-the-art biotechnology manufacturing and process development capabilities as we aspire to reach the potential of our supply pipeline for patients.
With a track record of delivering high-quality, reliably supplied biologic medicines, Amgen is proud of our history and excited for the future as we continue to focus on delivering our products, including biosimilars, to every patient, every time.
Visit our manufacturing section to learn more.